Chondrosarcoma natural history
Jump to navigation Jump to search
Chondrosarcoma natural history On the Web
American Roentgen Ray Society Images of Chondrosarcoma natural history
Risk calculators and risk factors for Chondrosarcoma natural history
Editor-In-Chief: C. Michael Gibson, M.S., M.D. ; Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.
Complications that can develop as a result of chondrosarcoma are metastasis and recurrence. The prognosis of chondrosarcoma correlates with the grade and stage of the lesion at the time of diagnosis. Chondrosarcoma is associated with a 5 year survival rate of 70%. The presence of grade 3 lesions are associated with a particularly poor prognosis.
Natural History, Complications, and Prognosis
- Chondrosarcoma may metastatize to other organs.
- Lung is the most common location for metastatic disease.
- Chondrosarcoma can rarely metastatize to skin.
- Chondrosarcoma may recur and may need treatment with surgery, chemotherapy or radiation.
- Unlike other cancers, chondrosarcoma can return many years later.
- Follow up scans are extremely important for chondrosarcoma to make sure there has been no recurrence or metastasis.
- The prognosis of chondrosarcoma correlates with the grade and stage of the lesion at the time of diagnosis.
- Depending upon the subtype, prognosis vary substantially:
- Clear cell chondrosarcoma: 70% survival rate at 5 years.
- Myxoid chondrosarcoma: 70% survival rate at 5 years.
- Mesenchymal chondrosarcoma: < 50% survival rate at 5 years.
- Dedifferentiated chondrosarcoma: 10% survival rate after 1 year.
- Prognosis varies with location:
- Long bones have a better prognosis than axial skeleton.
- ↑ 1.0 1.1 Lalam RK, Cassar-Pullicino VN, Kumar N, Cool WP, Cribb GL, Mangham DC (2015). "Subcutaneous and lung metastases from chondrosarcoma of the thumb". BJR Case Rep. 1 (3): 20150129. doi:10.1259/bjrcr.20150129. PMC 6180831. PMID 30363596.
- ↑ Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E; et al. (1999). "Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas". Hum Pathol. 30 (10): 1247–53. PMID 10534175.
- ↑ Evans HL, Ayala AG, Romsdahl MM (1977). "Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading". Cancer. 40 (2): 818–31. PMID 890662.
- ↑ Dorfman HD, Czerniak B. Bone Tumors. St Louis: Mosby; 1998. 353-440.
- ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.